These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 16494632)
1. Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. Moyle GJ; Brown S; Lysakova L; Barton SE HIV Med; 2006 Apr; 7(3):181-5. PubMed ID: 16494632 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. Burgess CM; Quiroga RM J Am Acad Dermatol; 2005 Feb; 52(2):233-9. PubMed ID: 15692467 [TBL] [Abstract][Full Text] [Related]
3. Retreatment with injectable poly-l-lactic acid for HIV-associated facial lipoatrophy: 24-month extension of the Blue Pacific study. Mest DR; Humble GM Dermatol Surg; 2009 Feb; 35 Suppl 1():350-9. PubMed ID: 19207325 [TBL] [Abstract][Full Text] [Related]
4. Poly-L-lactic acid injection for HIV-associated facial lipoatrophy: treatment principles, case studies, and literature review. Kates LC; Fitzgerald R Aesthet Surg J; 2008; 28(4):397-403. PubMed ID: 19083552 [TBL] [Abstract][Full Text] [Related]
5. Semipermanent filler treatment of HIV-positive patients with facial lipoatrophy: long-term follow-up evaluating MR imaging and quality of life. van Rozelaar L; Kadouch JA; Duyndam DA; Nieuwkerk PT; Lutgendorff F; Karim RB Aesthet Surg J; 2014 Jan; 34(1):118-32. PubMed ID: 24334306 [TBL] [Abstract][Full Text] [Related]
6. Poly-L-lactic acid: a perspective from my practice. Sadick NS J Cosmet Dermatol; 2008 Mar; 7(1):55-60. PubMed ID: 18254813 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience. Mest DR; Humble G Dermatol Surg; 2006 Nov; 32(11):1336-45. PubMed ID: 17083585 [TBL] [Abstract][Full Text] [Related]
8. Poly-L-lactic acid: a new dimension in soft tissue augmentation. Rotunda AM; Narins RS Dermatol Ther; 2006; 19(3):151-8. PubMed ID: 16784514 [TBL] [Abstract][Full Text] [Related]
9. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. Moyle GJ; Lysakova L; Brown S; Sibtain N; Healy J; Priest C; Mandalia S; Barton SE HIV Med; 2004 Mar; 5(2):82-7. PubMed ID: 15012646 [TBL] [Abstract][Full Text] [Related]
10. Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up. Alijotas-Reig J; Garcia-Gimenez V; Vilardell-Tarres M Dermatology; 2009; 219(4):303-8. PubMed ID: 19797889 [TBL] [Abstract][Full Text] [Related]
16. Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles. Brandt FS; Cazzaniga A; Baumann L; Fagien S; Glazer S; Kenkel JM; Lowe NJ; Monheit GD; Narins RS; Rendon MI; Rohrich RJ; Werschler WP Aesthet Surg J; 2011 Jul; 31(5):521-8. PubMed ID: 21719865 [TBL] [Abstract][Full Text] [Related]
17. Poly-l-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up. Carey D; Baker D; Petoumenos K; Chuah J; Rogers GD; Watson J; Cooper DA; Emery S; Carr A; HIV Med; 2009 Mar; 10(3):163-72. PubMed ID: 19245538 [TBL] [Abstract][Full Text] [Related]
18. The face of HIV and AIDS: can we erase the stigma? Kavouni A; Catalan J; Brown S; Mandalia S; Barton SE AIDS Care; 2008 Apr; 20(4):485-7. PubMed ID: 18449827 [TBL] [Abstract][Full Text] [Related]
19. Poly-L-lactic acid. Perry CM Am J Clin Dermatol; 2004; 5(5):361-6; discussion 367-8. PubMed ID: 15554738 [TBL] [Abstract][Full Text] [Related]
20. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy]. Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]